1. HAS to be NICE?

   • Gérard de Pouvourville

   Editorial 19 February 2013 Pages: 363 - 366

2. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

   • Don Husereau
   • Michael Drummond
   • Elizabeth Loder

   OriginalPaper 26 March 2013 Pages: 367 - 372

3. Redistributional consequences of early childhood intervention

   • Tim Lohse
   • Peter F. Lutz
   • Christian Thomann

   Original Paper 23 February 2012 Pages: 373 - 381

4. Problems of priority change in kidney allocation and beyond

   • Marlies Ahlert
   • Hartmut Kliemt

   Original Paper 23 February 2012 Pages: 383 - 390

   

5. Bargaining and the provision of health services

   • Luigi Siciliani
   • Anderson Stanciole

   Original Paper 16 March 2012 Pages: 391 - 406

   

6. Terminal patients in Belgian nursing homes: a cost analysis

   • Steven Simoens
   • Betty Kutten
   • Johan Menten

   Original Paper 26 February 2012 Pages: 407 - 413

   

7. Effects of competition on hospital quality: an examination using hospital administrative data

   • Alfons Palangkaraya
   • Jongsay Yong

   Original Paper 07 March 2012 Pages: 415 - 429

8. Welfare-related health inequality: does the choice of measure matter?

   • Joachim R. Frick
   • Nicolas R. Ziebarth

   Original Paper 25 March 2012 Pages: 431 - 442

9. Diffusion of innovations in social interaction systems. An agent-based model for the introduction of new drugs in markets

   • Julio Pombo-Romero
   • Luis M. Varela
   • Carlos J. Ricoy

   Original Paper 10 April 2012 Pages: 443 - 455

   

10. Does the US health care safety net discourage private insurance coverage?

    • Xuezheng Qin
    • Gordon G. Liu

    Original Paper 19 April 2012 Pages: 457 - 469

    

11. The impact of time cost of physical exercise on health outcomes by older adults: the DR’s EXTRA Study

    • Virpi Kuvaja-Köllner
    • Hannu Valtonen
    • Rainer Rauramaa

    Original Paper 25 April 2012 Pages: 471 - 479

12. Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation—results for Canada, Italy, Sweden and Switzerland

    • Jonas Nilsson
    • Örjan Åkerborg
    • Peter Lindgren

    Original Paper 03 May 2012 Pages: 481 - 493

    

13. Drug expenditure of high-cost patients and their characteristics in Finland

    • Leena K. Saastamoinen
    • Jouko Verho

    Original Paper 12 May 2012 Pages: 495 - 502

14. Systems GMM estimates of the health care spending and GDP relationship: a note

    • Saten Kumar

    Original Paper 13 May 2012 Pages: 503 - 506

15. Lenalidomide for multiple myeloma: cost-effectiveness in patients with one prior therapy in England and Wales

    • Ruth E. Brown
    • Sean Stern
    • Steve Schey

    Original Paper 10 May 2012 Pages: 507 - 514

    

16. Inter-regional competition and quality in hospital care

    • Hiroshi Aiura

    Original Paper 22 May 2012 Pages: 515 - 526

    

17. Spending more money, saving more lives? The relationship between avoidable mortality and healthcare spending in 14 countries

    • Richard Heijink
    • Xander Koolman
    • Gert P. Westert

    Original Paper 08 June 2012 Pages: 527 - 538

    

18. Can EQ-5D and 15D be used interchangeably in economic evaluations? Assessing quality of life in post-stroke patients

    • Lene Lunde

    Original Paper 08 June 2012 Pages: 539 - 550

    

19. How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus

    • Thomas Wilke
    • Antje Groth
    • Frank Verheyen

    Original Paper 20 July 2012 Pages: 551 - 568